Join
Live feed
·
INSIDERFilingvia Quantisnow
Inhibikase Therapeutics Inc. logo

Amendment: New insider Cabell Christopher claimed ownership of 1,014,846 shares (SEC Form 3)

ByQuantisnow·Wall Street's wire, on your screen.
IKT· Inhibikase Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IKT (Inhibikase Therapeutics Inc.) and more on Quantisnow.